耳部针用于降低2型糖尿病的血糖:一个试点研究
1Department of Bioscience, Pacific College of Health and Science-New York, New York, NY, USA.
Medical acupuncture
|August 23, 2023
概括
耳部针在2型糖尿病患者 (T2DM) 中显著降低了血糖. 这项试点研究表明T2DM管理的可行,可访问的治疗选择.
科学领域:
- 整合和补充医学是整合和补充医学.
- 内分泌学 在内分泌学.
- 针研究 针研究
背景情况:
- 2型糖尿病 (T2DM) 是一个全球性的健康问题,在危地马拉等地区,治疗选择有限.
- 对T2DM血糖管理的耳部针的研究仍然很少.
- 耳部针是一种潜在的低成本,可访问的治疗途径.
研究的目的:
- 评估耳部针方案的可行性和有效性,以降低T2DM患者的血糖水平.
- 探索耳部针作为糖尿病管理的补充治疗方法.
- 评估患者对耳部针用于血糖控制的兴趣.
主要方法:
- 一个自我控制的试点研究,涉及28名T2DM参与者.
- 一个为期2周的耳部针治疗方案,每位参与者使用5个特定的耳点.
- 配对t测试用于分析治疗前和后的禁食和食后血糖水平.
主要成果:
- 在禁食 (平均45.35分) 和食后 (平均109.45分) 血糖水平均有显著降低.
- 高参与者兴趣 (100%) 在持续的耳部针糖尿病管理.
- 患者报告的关于健康状况和生活质量的积极结果.
结论:
- 耳部针方案显示出作为一种低成本,有效的干预措施来降低T2DM中的血糖的潜力.
- 这些发现支持进一步调查耳部针在T2DM护理中的作用.
- 耳部针可能为2型糖尿病患者提供可行的,可访问的治疗选择.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
205
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
205
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K


